Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07197502 · ClinicalTrials.gov registry record · NA
Treatment of Borderline Personality Disorder With rTMS
A NA study of Borderline Personality Disorder and Borderline Personality, sponsored by University of California, Los Angeles.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 2
- Study locations
NCT07197502 is a NA study of Borderline Personality Disorder and Borderline Personality that is actively recruiting participants, run by University of California, Los Angeles. The registered enrollment target is 30 participants, below the 106-participant average among 16 other Borderline Personality Disorder trials with a reported enrollment target (72% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT07197502, a NA study of Borderline Personality Disorder and Borderline Personality, is actively recruiting participants, sponsored by University of California, Los Angeles.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
This project studies the effectiveness of brain stimulation on borderline personality disorder (BPD) symptoms. This study is blinded, randomized and will enroll up to 30 participants. Participant will be consented for the study remotely via a secure internet platform called Zoom. Participants will undergo up to 2 MRI scans, 2 brain wave recording sessions and up to 30 brain stimulation treatments, and complete symptom assessments and cognitive behavioral tasks on a computer. Participation requires minimum of 17 in person visits over the course of 2.5 months. Participants are randomly assigned active or sham brain stimulation. Participants who received sham brain stimulation have the option to receive additional 15 active brain stimulation session.
Conditions Studied
Interventions
- DEVICE Transcranial Magnetic Stimulation (TMS)
Study Locations (2)
California
- Semel Institute for Neuroscience and Human Behavior at UCLA - Los Angeles
- Semel Institute/ UCLA TMS - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2025-03-01 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07197502
The ClinicalTrials.gov registry entry for NCT07197502 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 106-participant average among 16 other Borderline Personality Disorder trials with a reported enrollment target (72% lower). The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Borderline Personality Disorder appearing as the primary indexed condition, and to 1 intervention - of which Transcranial Magnetic Stimulation (TMS) is the first listed.
NCT07197502 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT07197502 about?
NCT07197502 is a clinical study titled "Treatment of Borderline Personality Disorder With rTMS". This project studies the effectiveness of brain stimulation on borderline personality disorder (BPD) symptoms. This study is blinded, randomized and will enroll up to 30 participants. Participant will be consented for the study remotely via a secure internet platform called Zoom. Participants will...
What is the current status of trial NCT07197502?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-03-01. Estimated completion is 2027-12-31.
What conditions does trial NCT07197502 study?
This clinical trial studies the following conditions: Borderline Personality Disorder, Borderline Personality, BPD - Borderline Personality Disorder.
What interventions are being tested in trial NCT07197502?
The interventions under investigation include: Transcranial Magnetic Stimulation (TMS) (DEVICE).
Who is sponsoring clinical trial NCT07197502?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07197502 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Borderline Personality Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
RECRUITING · NA
-
Cognitive Reappraisal Training for Borderline Personality (BPD)
RECRUITING · NA
-
Circuit-Based Approach to Suicide: Biomarkers, Predictors, and Novel Therapeutics
RECRUITING · NA
-
PILOT Phase: BPD Study
ACTIVE NOT RECRUITING · NA
-
Neurofeedback for Borderline Personality Disorder
ACTIVE NOT RECRUITING · NA
-
Personality Change Study for Borderline Personality Disorder
ACTIVE NOT RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.